Mimcipar 60mg Tablet
- Manufacturer : Panacea Biotec Ltd.
- Composition : Cinacalcet 60mg
- Generally Prescribed For : Hyperparathyroidism
- Estimated Price : ₹1,224.82 For 10 Tablets Strip
BUY FROM THESE SELLERS
Uses of Mimcipar 60mg TabletMimcipar 60mg Tablet is used for the treatment or prevention of the following disease(s):
Side effects of Mimcipar 60mg TabletThe most common side effects of Mimcipar 60mg Tablet are - Dizziness, Asthenia, Seizures, Depression, Fatigue, Headache, Paresthesia, Chest Pain, Hypertension, Diarrhea, Nausea, Vomiting, Anorexia, Constipation, Anemia, Hypocalcemia
These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.
Precautions while using Mimcipar 60mg TabletDo not use Mimcipar 60mg Tablet if you are allergic to - Cinacalcet
If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Mimcipar 60mg Tablet.
If you are allergic to any medicine or food, consult your doctor before using this medicine.
Use this medicine under the supervision of your doctor.
To avoid an adverse reaction, consult your doctor if you are already taking other medicines.
How Mimcipar 60mg Tablet worksMimcipar 60mg Tablet contains - Cinacalcet
Cinacalcet increases sensitivity of calcium-sensing receptor to extracellular calcium, letting calcium be absorbed despite decreased PTH.
Dosage of Mimcipar 60mg TabletThe dosage of Mimcipar 60mg Tablet depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.
Please use this medicine as prescribed by your doctor.
Overdose of Mimcipar 60mg TabletIf you forget to take a dose of Mimcipar 60mg Tablet, do not take two doses at the same time, there is a risk of overdose.
If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.
Precautions & Warnings
InteractionDrug :- Amitriptyline: Amitriptyline and nortriptyline exposure increases by 20% in patients who are CYP2D6 extensive metabolizers. Avoid using together, if possible.
Drugs metabolized mainly by CYP2D6 with a narrow therapeutic index (flecainide, thioridazine, most TCAs, vinblastine): May strongly inhibit CYP2D6, decreasing metabolism and increasing levels of these drugs. Adjust dosage of other drugs, as needed.
Drugs that strongly inhibit CYP3A4 (erythromycin, itraconazole, ketoconazole): May increase cinacalcet level. Use together cautiously, monitoring PTH and calcium level closely and adjusting cinacalcet dosage, as needed.